November 2013 FDA Recall Drug by Actavis Elizabeth Llc
D-1087-2014 - Subpotent Drug

This Class II drug recall was voluntarily initiated by Actavis Elizabeth Llc on November 6, 2013 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1087-2014

Reason for Recall
Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.
Initiated
11-06-2013
Reported
03-05-2014
Quantity
13,608 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Actavis Elizabeth LLC
Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USA NDC 0228-3005-11 packaged in White/Round HDPE 75 CC with white/round plastic 33 mm CRC closure shipped in corrugated 75 cc carton (24 bottles/carton)

Batch or Lot Expiration Information

Lot# lot 58468552 Exp. 05/15